1. Histological findings in chilblain lupus‐like COVID lesions: in search of an answer to understand their aetiology
- Author
-
Lidia Trasobares-Marugán, Dolores Vélez-Velázquez, Alba Gómez-Zubiaur, David Vega-Díez, Marta González-Cañete, Marta Bandini, A. Rodríguez‐Villa Lario, R. Pérez‐Mesonero, and Isabel Polo-Rodríguez
- Subjects
skin ,2019-20 coronavirus outbreak ,medicine.medical_specialty ,Coronavirus disease 2019 (COVID-19) ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,virus ,Dermatology ,Letter to Editor ,Viral infection ,SARS‐CoV‐2 ,030207 dermatology & venereal diseases ,03 medical and health sciences ,0302 clinical medicine ,Lupus Erythematosus, Cutaneous ,medicine ,Humans ,Letters to Editor ,COVID ,030203 arthritis & rheumatology ,Systemic lupus erythematosus ,SARS-CoV-2 ,business.industry ,COVID-19 ,CHILBLAIN LUPUS ,lupus ,interferon ,medicine.disease ,Chilblains ,Infectious Diseases ,Etiology ,acro‐ischemia ,business ,chilblain - Abstract
We read with great interest the article by Piccolo et al1. describing chilblain‐like lesions (CLL) on feet and hands during the COVID‐19 Pandemic. They mention the rate of association to autoimmune conditions was very low, which led the to exclude a note autoimmune disorder as main cause of CLL. Here, we hypothesize the possible relationship between the development of these lesions and immune‐chained phenomena following viral infection in a certain group of patients.
- Published
- 2020
- Full Text
- View/download PDF